Human Subjects Office releases new FDA Site Inspection Guidance [1]
The Food and Drug Administration (FDA) conducts site inspections of clinical investigators involved in FDA-regulated clinical trials to determine compliance with applicable regulations. The Human Subjects Office (HSO) Compliance Staff has released the newly created FDA Site Inspection Guidance [2] to provide practical advice for Principal Investigators (PI) and research staff undergoing a FDA inspection.